Pharmaceutical Demand And Digital Automation Will Shape Future Markets

Published
18 Jul 24
Updated
20 Aug 25
AnalystConsensusTarget's Fair Value
US$788.57
12.6% undervalued intrinsic discount
20 Aug
US$689.45
Loading
1Y
24.9%
7D
2.4%

Author's Valuation

US$788.6

12.6% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on07 May 25
Fair value Increased 6.77%

Shared on30 Apr 25
Fair value Increased 0.92%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on23 Apr 25
Fair value Increased 1.10%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on16 Apr 25
Fair value Increased 1.85%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Increased 1.54%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Increased 4.76%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25
Fair value Increased 0.78%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on10 Mar 25
Fair value Decreased 13%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.